ATC code none CAS Number 925448-93-7 ChemSpider 17231095 Molar mass 409.501 g/mol | Legal status Investigational PubChem CID 16071605 KEGG D10099 | |
 | ||
Cerlapirdine (USAN; SAM-531, WAY-262,531, PF-05212365) is a drug which was under development by Wyeth/Pfizer for the treatment of cognitive disorders associated with Alzheimer's disease and schizophrenia. In a phase II clinical trial it demonstrated a trend toward efficacy along with a good side effect profile and no incidence of serious adverse events, but no further development has occurred since 2011.
It exerts its effects by acting as a selective 5-HT6 receptor antagonist.
References
Cerlapirdine Wikipedia(Text) CC BY-SA